Cohen; Charles M.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Cohen; Charles M..The latest application filed is for "novel therapies for chronic renal failure".
Company Profile
0.31.14
- Cohen; Charles M. - Weston MA
- Cohen; Charles M - Weston MA
- Cohen; Charles M. - Medway MA
Patent Activity
| Patent | Date |
|---|---|
| Therapies for acute renal failure Grant 8,748,378 - Cohen , et al. June 10, 2 | 2014-06-10 |
| Therapies for chronic renal failure Grant 8,377,878 - Sampath , et al. February 19, 2 | 2013-02-19 |
| Novel Therapies For Chronic Renal Failure App 20120004171 - Sampath; Kuber T. ; et al. | 2012-01-05 |
| Therapies For Acute Renal Failure App 20110257093 - Cohen; Charles M. ; et al. | 2011-10-20 |
| Therapies for chronic renal failure Grant 8,017,580 - Cohen , et al. September 13, 2 | 2011-09-13 |
| Novel Therapies For Chronic Renal Failure App 20100291170 - SAMPATH; KUBER T. ; et al. | 2010-11-18 |
| Therapies for acute renal failure App 20100105621 - Cohen; Charles M. ; et al. | 2010-04-29 |
| Morphogen-induced nerve regeneration and repair Grant 7,557,078 - Rueger , et al. July 7, 2 | 2009-07-07 |
| Therapies for chronic renal failure Grant 7,524,817 - Cohen , et al. April 28, 2 | 2009-04-28 |
| Protein-induced morphogenesis of kidney tissue Grant 7,196,056 - Cohen , et al. March 27, 2 | 2007-03-27 |
| Methods for evaluating tissue morphogenesis and activity Grant 7,147,839 - Sampath , et al. December 12, 2 | 2006-12-12 |
| Product and process for the production, isolation, and purification of recombinant polypeptide Grant 7,105,638 - Huston , et al. September 12, 2 | 2006-09-12 |
| Morphogen treatments for limiting proliferation of epithelial cells Grant 7,060,680 - Cohen , et al. June 13, 2 | 2006-06-13 |
| Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases Grant 7,056,882 - Kuberasampath , et al. June 6, 2 | 2006-06-06 |
| Morphogen-induced dendritic growth App 20060025571 - Rueger; David C. ; et al. | 2006-02-02 |
| Morphogen-induced dendritic growth Grant 6,949,505 - Rueger , et al. September 27, 2 | 2005-09-27 |
| Novel therapies for chronic renal failure App 20050143304 - Cohen, Charles M. ; et al. | 2005-06-30 |
| Morphogen-induced modulation of inflammatory response App 20050096339 - Kuberasampath, Thangavel ; et al. | 2005-05-05 |
| Methods and compositions for the treatment of motor neuron injury and neuropathy App 20050065083 - Rueger, David C. ; et al. | 2005-03-24 |
| Therapies for chronic renal failure Grant 6,861,404 - Cohen , et al. March 1, 2 | 2005-03-01 |
| Morphogen-induced neural cell adhesion Grant 6,800,603 - Rueger , et al. October 5, 2 | 2004-10-05 |
| Protein-induced morphogenesis App 20040102373 - Cohen, Charles M. ; et al. | 2004-05-27 |
| Methods and compositions for the treatment of motor neuron injury and neuropathy Grant 6,723,698 - Rueger , et al. April 20, 2 | 2004-04-20 |
| Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases App 20030224979 - Kuberasampath, Thangavel ; et al. | 2003-12-04 |
| Morphogen treatments for limiting proliferation of epithelial cells App 20030125230 - Cohen, Charles M. ; et al. | 2003-07-03 |
| Methods For Evaluating Tissue Morphogenesis And Activity App 20030109686 - SAMPATH, KUBER T. ; et al. | 2003-06-12 |
| Morphogen-induced Nerve Regeneration And Repair App 20030104993 - RUEGER, DAVID C. ; et al. | 2003-06-05 |
| Morphogen treatment for chronic renal failure Grant 6,498,142 - Sampath , et al. December 24, 2 | 2002-12-24 |
| Methods And Compositions For The Treatment Of Motor Neuron Injury And Neuropathy App 20020049159 - RUEGER, DAVID C. ; et al. | 2002-04-25 |
| 60A protein-induced morphogenesis Grant 6,211,146 - Kuberasampath , et al. April 3, 2 | 2001-04-03 |
| Morphogen-enriched dietary composition Grant 6,022,853 - Kuberasampath , et al. February 8, 2 | 2000-02-08 |
| Morphogen treatment of gastrointestinal ulcers Grant 5,972,884 - Cohen , et al. October 26, 1 | 1999-10-26 |
| Morphogen-induced liver regeneration Grant 5,849,686 - Kuberasampath , et al. December 15, 1 | 1998-12-15 |
| Morphogen treatment of gastrointestinal ulcers Grant 5,739,107 - Cohen , et al. April 14, 1 | 1998-04-14 |
| Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases Grant 5,674,844 - Kuberasampath , et al. October 7, 1 | 1997-10-07 |
| Morphogen induced periodontal tissue regeneration Grant 5,656,593 - Kuberasampath , et al. August 12, 1 | 1997-08-12 |
| OP-3-induced morphogenesis Grant 5,652,337 - Oppermann , et al. July 29, 1 | 1997-07-29 |
| Synthetic bioadhesive Grant 5,374,431 - Pang , et al. December 20, 1 | 1994-12-20 |
| Leader sequences for the production of recombinant proteins Grant 5,215,896 - Keck , et al. June 1, 1 | 1993-06-01 |
| Synthetic bioadhesive Grant 5,197,973 - Pang , et al. March 30, 1 | 1993-03-30 |
| Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage Grant 5,013,653 - Huston , et al. May 7, 1 | 1991-05-07 |
| Process for producing human epidermal growth factor and analogs thereof Grant 5,004,686 - Cohen , et al. April 2, 1 | 1991-04-02 |
| Process for producing human epidermal growth factor and analogs thereof Grant 4,743,679 - Cohen , et al. May 10, 1 | 1988-05-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 